Related Experiment Videos

Re: Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line

A Grothey, P D McCrea

Journal of the National Cancer Institute

|April 16, 1998

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

MODUL cohort 2: an adaptable, randomized, signal-seeking trial of fluoropyrimidine plus bevacizumab with or without atezolizumab maintenance therapy for BRAFwt metastatic colorectal cancer.

ESMO open·2022

Quality of life with encorafenib plus cetuximab with or without binimetinib treatment in patients with BRAF V600E-mutant metastatic colorectal cancer: patient-reported outcomes from BEACON CRC.

ESMO open·2022

Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC study.

ESMO open·2021

Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Distinct genomic landscapes of gastroesophageal adenocarcinoma depending on PD-L1 expression identify mutations in RAS-MAPK pathway and TP53 as potential predictors of immunotherapy efficacy.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

See all related articles